Back to AZN Stock Lookup

AstraZeneca plc (AZN) –

Jan 28, 2015 09:48 AM ARIAD Pharma (ARIA) Rumored to Be Takeover Target
Jan 22, 2015 02:24 PM Form SC 13G/A ASTRAZENECA PLC Filed by: BlackRock Inc.
Jan 22, 2015 09:44 AM Form 6-K ASTRAZENECA PLC For: Jan 22
Jan 16, 2015 10:49 AM Notable Analyst Rating Changes 1/16: (TUBE) (NFLX) (APC) Upgraded; (AYR) (RGC) (GPS) Downgraded
Jan 16, 2015 09:08 AM Barclays Downgrades AstraZeneca (AZN) to Underweight
Jan 14, 2015 07:39 AM AstraZeneca plc (AZN) Reports PEGASUS-TIMI 54 Met Primary Endpoint
Jan 14, 2015 07:00 AM PEGASUS-TIMI 54 Study of BRILINTA® Meets Primary Endpoint in Both 60mg and 90mg Doses
Jan 14, 2015 06:27 AM Form 6-K ASTRAZENECA PLC For: Jan 14
Jan 12, 2015 02:00 AM QIAGEN Announces First-ever Regulatory Registration of a Lung Cancer Companion Diagnostic Based on Liquid Biopsies
Jan 5, 2015 08:22 AM JPMorgan Upgrades AstraZeneca (AZN) to Neutral
Jan 2, 2015 12:20 PM Form 6-K ASTRAZENECA PLC For: Jan 02
Dec 19, 2014 03:22 PM AstraZeneca (AZN) Affirms LYNPARZA Approved by FDA in Ovarian Cancer
Dec 19, 2014 01:10 PM Form 6-K ASTRAZENECA PLC For: Dec 19
Dec 19, 2014 12:12 PM Myriad Genetics (MYGN) Receives FDA Approval for BRACAnalysis CDx as Companion Diagnostic (AZN)
Dec 19, 2014 11:44 AM AstraZeneca (AZN): FDA Approves Lynparza to Treat Advanced Ovarian Cancer
Dec 18, 2014 06:04 AM Form 6-K ASTRAZENECA PLC For: Dec 18
Dec 11, 2014 04:02 PM Amgen (AMGN), AstraZeneca (AZN) to Present Brodalumab Phase 3 Results at Psoriasis: From Gene to Clinic Congress
Dec 11, 2014 04:01 PM Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
Dec 9, 2014 08:17 AM Nektar Therapeutics (NKTR) Affirms Receipt of EC Marketing Approval for MOVENTIG
Dec 9, 2014 07:46 AM AstraZeneca's (AZN) MOVENTIG Receives Marketing Approval from EC
Dec 9, 2014 07:42 AM Form 6-K ASTRAZENECA PLC For: Dec 09
Dec 8, 2014 07:08 AM AstraZeneca (ANZ) to Fully Fund Dynavax's (DVAX) Phase 2a Safety, Efficacy Trial of AZD1419
Dec 5, 2014 12:38 PM Form 6-K ASTRAZENECA PLC For: Dec 05
Dec 4, 2014 03:00 PM Infinata’s BioPharm Insight 3Q14 Licensing League Table Report Reflects Robust Growth in Biotech, Pharmaceutical Industries
Dec 4, 2014 10:22 AM Jefferies Names Top 2015 Pharmaceutical Picks (PFE) (NVS) (more...)
Dec 2, 2014 11:41 AM Morgan Stanley Downgrades AstraZeneca (AZN) to Underweight
Dec 2, 2014 10:07 AM Form 6-K ASTRAZENECA PLC For: Dec 01
Dec 1, 2014 09:51 AM Form 6-K ASTRAZENECA PLC For: Dec 01
Dec 1, 2014 07:19 AM Form 6-K ASTRAZENECA PLC For: Dec 01
Dec 1, 2014 07:03 AM Lilly & Co. (LLY), AstraZeneca (AZN) Enroll First Patient in AMARANTH
Nov 26, 2014 08:16 AM Form 6-K/A ASTRAZENECA PLC For: Nov 26
Nov 26, 2014 06:44 AM Mylan (MYL) Most Likely Takeover Targer for Pfizer (PFE) - Jefferies
Nov 25, 2014 04:03 PM Amgen (AMGN), AstraZeneca (AZN) Report AMAGINE-2 Met Primary Endpoints
Nov 25, 2014 04:01 PM Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
Nov 25, 2014 07:58 AM Exane BNP Paribas Starts AstraZeneca (AZN) at Outperform
Nov 24, 2014 11:53 AM Form 6-K ASTRAZENECA PLC For: Nov 24
Nov 24, 2014 06:47 AM Form 6-K ASTRAZENECA PLC For: Nov 24
Nov 21, 2014 11:08 AM AstraZeneca Announces Plans to Expand its Frederick, Maryland Biologics Manufacturing Center
Nov 19, 2014 12:24 PM Form 6-K ASTRAZENECA PLC For: Nov 19
Nov 19, 2014 11:37 AM Global Oncology Market to hit $109 billion - Spotlight on Drug Life Cycle Management, M&A and Pipeline Strategies
Nov 18, 2014 06:37 AM AstraZeneca plc (AZN) Comments on Strategic Priorities Ahead of Investor/Analyst Day
Nov 18, 2014 06:29 AM Form 6-K ASTRAZENECA PLC For: Nov 18
Nov 17, 2014 01:40 PM Pfizer/Merck Deal Lowers Probablity of Renewed AstraZeneca (AZN) Deal - BofA/Merrill Lynch
Nov 17, 2014 12:04 PM Form 6-K ASTRAZENECA PLC For: Nov 17
Nov 17, 2014 07:00 AM MedImmune Presents Promising New Data in Systemic Lupus at American College of Rheumatology Meeting
Nov 17, 2014 07:00 AM MedImmune Presents Positive Phase IIb Data for Mavrilimumab in Rheumatoid Arthritis at ACR Annual Meeting
Nov 16, 2014 09:00 AM AstraZeneca Presents Data from Phase III Studies of Lesinurad in Combination with Allopurinol in Gout Patients at American College of Rheumatology 2014 Annual Meeting
Nov 14, 2014 04:21 PM Loeb's Third Point LLC 13F Shows New Stakes in Alibaba (BABA), Bed Bath & Beyond (BBBY), Crown (CCK), eBay (EBAY), and More!
Nov 13, 2014 09:09 AM Pre-Open Stock Movers 11/13: (DWA) (FUEL) (CYBR) Higher; (BAXS) (MNK) (SPWR) Lower (more...)
Nov 13, 2014 07:00 AM AstraZeneca Announces Initiation of Development Program for BRILINTA (ticagrelor) Reversal Agent

Back to AZN Stock Lookup